Study Description: We are conducting this research study to find out whether a treatment that raises urate levels can slow the rate of worsening in Parkinsons disease. Urate, also known as uric acid, is a substance that is a normal part of the body and is found in blood and brain. There is evidence that increased urate levels can predict both a lower risk of developing PD and a slower rate of its worsening over time.
Principal Investigator: John Morgan
Eligibility Criteria: Diagnosed with Parkinsons Disease and age 30 or older
Compensation: Yes, subjects will be compensated.
Compensation Explanation: You will not be paid for taking part in this study. However, starting with the Baseline Visit you will receive $80 after each in-person study visit that you complete. This is to reimburse you for travel and meal costs involved in coming to the study visit. Reimbursement will be by debit card. Please note that it may take up to two weeks after each visit for the payment for that visit to be loaded to the debit card and become available for use. Do not discard or toss out this debit card over the course of the study. The same card will be used to reimburse you for travel and meal costs. Paymentreceived as a research subject may be taxable income to you. If you receive payment more than $600.00 in a calendar year, the study team is required to report this to the Internal Revenue Service (IRS). An IRS For 1099 (Miscellaneous Income) will be issued to you and a copy sent to the IRS. If you are required to complete an IRS Form 1099 you will be asked to provide your social security number to the research staff.
If you don't see specific studies that interest you, please submit your contact information for future studies.